Literature DB >> 2416768

Specific labelling of human rotaviruses and adenoviruses with gold-IgG complexes.

E Kjeldsberg.   

Abstract

Human rotaviruses and adenoviruses were specifically labelled by an indirect immuno gold staining technique for electron microscopy. Rabbit antisera against human rota- and adenoviruses were used as the primary antibody and goat anti-rabbit IgG-gold complexes as secondary antibody. Optimal conditions for the procedure were established by testing serial dilutions of the antisera. Precoating of electron microscopy grids with bovine rotavirus antibody decreased nonspecific background staining and at the same time increased slightly the number of virus particles adsorbed to the grid. Noncultivable enteric adenoviruses showed no antigenic relationship to adenovirus type 2 and 6 from cell culture material when tested by this gold labelled antibody decoration technique. However, a slight cross-reaction was observed between adenovirus type 2 and type 6.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416768     DOI: 10.1016/0166-0934(85)90007-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  4 in total

1.  Sensitive solid-phase immune electron microscopy double-antibody technique with gold-immunoglobulin G complexes for detecting rotavirus in cell culture and feces.

Authors:  B Wu; J B Mahony; G Simon; M A Chernesky
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

Review 2.  Applications of immunogold labelling in animal and plant virology.

Authors:  S Patterson; B J Verduin
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

Review 3.  Human viral gastroenteritis.

Authors:  M L Christensen
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

4.  Evaluation of an immunogold electron microscopy technique for detecting bovine coronavirus.

Authors:  A A el-Ghorr; D R Snodgrass; F M Scott
Journal:  J Virol Methods       Date:  1988 Mar-Apr       Impact factor: 2.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.